Björn Wettermark

Summary

Affiliation: Karolinska Institutet
Country: Sweden

Publications

  1. doi request reprint The Nordic prescription databases as a resource for pharmacoepidemiological research--a literature review
    B Wettermark
    Centre for Pharmacoepidemiology, Department of Medicine, Karolinska Institutet, Stockholm, Sweden
    Pharmacoepidemiol Drug Saf 22:691-9. 2013
  2. doi request reprint The intriguing future of pharmacoepidemiology
    Björn Wettermark
    Karolinska Institutet, Centre for Pharmacoepidemiology, Department of Medicine, Clinical Epidemiology Unit T2, Karolinska University Hospital, SE 171 76 Stockholm, Sweden
    Eur J Clin Pharmacol 69:43-51. 2013
  3. doi request reprint Soft regulations in pharmaceutical policy making: an overview of current approaches and their consequences
    Björn Wettermark
    Department of Clinical Pharmacology, Karolinska Institutet, Stockholm, Sweden
    Appl Health Econ Health Policy 7:137-47. 2009
  4. doi request reprint Initial effects of a reimbursement restriction to improve the cost-effectiveness of antihypertensive treatment
    Björn Wettermark
    Karolinska Institutet, Centre for Pharmacoepidemiology, Clinical Epidemiology Unit, Department of Medicine, Karolinska Institutet, Stockholm, Sweden
    Health Policy 94:221-9. 2010
  5. doi request reprint Initiatives to enhance renin-angiotensin prescribing efficiency in Austria: impact and implications for other countries
    Brian Godman
    Department of Laboratory Medicine, Division of Clinical Pharmacology, Karolinska Institutet, Karolinska University Hospital Huddinge, SE 141 86, Stockholm, Sweden
    Expert Rev Pharmacoecon Outcomes Res 10:199-207. 2010
  6. doi request reprint The 'wise list'- a comprehensive concept to select, communicate and achieve adherence to recommendations of essential drugs in ambulatory care in Stockholm
    Lars L Gustafsson
    Division of Clinical Pharmacology, Department of Laboratory Medicine, Karolinska Institutet at Karolinska University Hospital Huddinge, Stockholm, Sweden
    Basic Clin Pharmacol Toxicol 108:224-33. 2011
  7. ncbi request reprint The new Swedish Prescribed Drug Register--opportunities for pharmacoepidemiological research and experience from the first six months
    Björn Wettermark
    Division of Clinical Pharmacology, Karolinska University Hospital, Huddinge, Karolinska Institutet, Stockholm, Sweden
    Pharmacoepidemiol Drug Saf 16:726-35. 2007
  8. ncbi request reprint A study of adherence to drug recommendations by providing feedback of outpatient prescribing patterns to hospital specialists
    Björn Wettermark
    Department of Laboratory Medicine, Division of Clinical Pharmacology, Karolinska Institute, WHO Collaborating Centre for Drug Utilization Research and Clinical Pharmacological Services, Huddinge, Stockholm, Sweden
    Pharmacoepidemiol Drug Saf 14:579-88. 2005
  9. doi request reprint Utilisation of angiotensin receptor blockers in Sweden: combining survey and register data to study adherence to prescribing guidelines
    Pia Frisk
    National Corporation of Swedish Pharmacies Apoteket AB, SE 118 81, Stockholm, Sweden
    Eur J Clin Pharmacol 64:1223-9. 2008
  10. ncbi request reprint Recent national and regional drug reforms in Sweden: implications for pharmaceutical companies in Europe
    Björn Wettermark
    Division of Clinical Pharmacology, Department of Laboratory Medicine, Karolinska Institute, Stockholm, Sweden
    Pharmacoeconomics 26:537-50. 2008

Detail Information

Publications25

  1. doi request reprint The Nordic prescription databases as a resource for pharmacoepidemiological research--a literature review
    B Wettermark
    Centre for Pharmacoepidemiology, Department of Medicine, Karolinska Institutet, Stockholm, Sweden
    Pharmacoepidemiol Drug Saf 22:691-9. 2013
    ..The aim of this review is to present an overview of therapeutic areas studied and methods applied in pharmacoepidemiologic studies using data from these databases...
  2. doi request reprint The intriguing future of pharmacoepidemiology
    Björn Wettermark
    Karolinska Institutet, Centre for Pharmacoepidemiology, Department of Medicine, Clinical Epidemiology Unit T2, Karolinska University Hospital, SE 171 76 Stockholm, Sweden
    Eur J Clin Pharmacol 69:43-51. 2013
    ..A potential threat is that the increasing amounts of data available in registries may add fuel to the debate on confidentiality. The too strict application of privacy rules might hinder the further development of pharmacoepidemiology...
  3. doi request reprint Soft regulations in pharmaceutical policy making: an overview of current approaches and their consequences
    Björn Wettermark
    Department of Clinical Pharmacology, Karolinska Institutet, Stockholm, Sweden
    Appl Health Econ Health Policy 7:137-47. 2009
    ..We hope this opinion paper is the first step in the process to develop and implement new demand-side initiatives building on existing 'soft regulations'...
  4. doi request reprint Initial effects of a reimbursement restriction to improve the cost-effectiveness of antihypertensive treatment
    Björn Wettermark
    Karolinska Institutet, Centre for Pharmacoepidemiology, Clinical Epidemiology Unit, Department of Medicine, Karolinska Institutet, Stockholm, Sweden
    Health Policy 94:221-9. 2010
    ..This resulted in reimbursement restrictions for 26 substances, e.g. all angiotensin receptor blockers (ARBs)...
  5. doi request reprint Initiatives to enhance renin-angiotensin prescribing efficiency in Austria: impact and implications for other countries
    Brian Godman
    Department of Laboratory Medicine, Division of Clinical Pharmacology, Karolinska Institutet, Karolinska University Hospital Huddinge, SE 141 86, Stockholm, Sweden
    Expert Rev Pharmacoecon Outcomes Res 10:199-207. 2010
    ....
  6. doi request reprint The 'wise list'- a comprehensive concept to select, communicate and achieve adherence to recommendations of essential drugs in ambulatory care in Stockholm
    Lars L Gustafsson
    Division of Clinical Pharmacology, Department of Laboratory Medicine, Karolinska Institutet at Karolinska University Hospital Huddinge, Stockholm, Sweden
    Basic Clin Pharmacol Toxicol 108:224-33. 2011
    ....
  7. ncbi request reprint The new Swedish Prescribed Drug Register--opportunities for pharmacoepidemiological research and experience from the first six months
    Björn Wettermark
    Division of Clinical Pharmacology, Karolinska University Hospital, Huddinge, Karolinska Institutet, Stockholm, Sweden
    Pharmacoepidemiol Drug Saf 16:726-35. 2007
    ..To describe the content and potentials of the new Swedish national register on prescribed and dispensed medicines...
  8. ncbi request reprint A study of adherence to drug recommendations by providing feedback of outpatient prescribing patterns to hospital specialists
    Björn Wettermark
    Department of Laboratory Medicine, Division of Clinical Pharmacology, Karolinska Institute, WHO Collaborating Centre for Drug Utilization Research and Clinical Pharmacological Services, Huddinge, Stockholm, Sweden
    Pharmacoepidemiol Drug Saf 14:579-88. 2005
    ....
  9. doi request reprint Utilisation of angiotensin receptor blockers in Sweden: combining survey and register data to study adherence to prescribing guidelines
    Pia Frisk
    National Corporation of Swedish Pharmacies Apoteket AB, SE 118 81, Stockholm, Sweden
    Eur J Clin Pharmacol 64:1223-9. 2008
    ..We analysed the prescribing patterns of ARBs in Sweden by combining prescription register data with patient self-reported data...
  10. ncbi request reprint Recent national and regional drug reforms in Sweden: implications for pharmaceutical companies in Europe
    Björn Wettermark
    Division of Clinical Pharmacology, Department of Laboratory Medicine, Karolinska Institute, Stockholm, Sweden
    Pharmacoeconomics 26:537-50. 2008
    ....
  11. pmc Forecasting drug utilization and expenditure in a metropolitan health region
    Björn Wettermark
    Department of Drug Management and Informatics, Stockholm County Council, Stockholm, Sweden
    BMC Health Serv Res 10:128. 2010
    ..The aim of this paper is to present the forecasting model and the predicted growth in all therapeutic areas in 2010 and 2011...
  12. doi request reprint Impact of recent reforms in Austria on utilization and expenditure of PPIs and lipid-lowering drugs: implications for the future
    Brian Godman
    Department of Laboratory Medicine, Division of Clinical Pharmacology, Karolinska Institutet, Karolinska University Hospital Huddinge, SE 141 86, Stockholm, Sweden
    Expert Rev Pharmacoecon Outcomes Res 9:475-84. 2009
    ..To assess the impact of a plethora of reforms and initiatives introduced in Austria since 2002 on the actual utilization and expenditure of proton pump inhibitors and statins...
  13. doi request reprint Regional variation and adherence to guidelines for drug treatment of asthma
    Marianne Heibert Arnlind
    Centre for Allergy Research, Karolinska Institutet, Stockholm, Sweden
    Eur J Clin Pharmacol 66:187-98. 2010
    ..To describe the utilization of antiasthmatic drugs in Sweden and to explore regional variations in drug utilization and adherence to guidelines for rational drug prescribing of antiasthmatics and their rationale...
  14. doi request reprint Extraction of electronic health record data in a hospital setting: comparison of automatic and semi-automatic methods using anti-TNF therapy as model
    Thomas Cars
    Public Healthcare Services Committee Administration, Stockholm County Council, Stockholm, Sweden
    Basic Clin Pharmacol Toxicol 112:392-400. 2013
    ..This methodological study showed the potential to extract drug therapy data in a hospital setting. The semi-automatic procedure produced an almost complete pattern of demographics, diagnoses and dosages for the treatment with infliximab...
  15. ncbi request reprint Adherence to guidelines for drug treatment of asthma in children: potential for improvement in Swedish primary care
    Maria Ingemansson
    Paediatric Department, Astrid Lindgrens Hospital, Karolinska University Hospital, Sweden
    Qual Prim Care 20:131-9. 2012
    ..Adherence to guidelines in general is poor. Because asthma is the most common chronic disease in Swedish children, identifying areas for improvement regarding drug treatment for asthma is crucial...
  16. ncbi request reprint Drug utilisation 90% profiles--a useful tool for quality assessment of prescribing in primary health care in Stockholm
    Björn Wettermark
    Department of Medical Laboratory Sciences, Division of Clinical Pharmacology, Karolinska Institute, Stockholm, Sweden
    Pharmacoepidemiol Drug Saf 12:499-510. 2003
    ..To analyse strengths and weaknesses of a simple method for assessing the general quality of drug prescribing and to study the acceptance of the method among general practitioners (GPs)...
  17. doi request reprint Changes in the utilization of venlafaxine after the introduction of generics in Sweden
    Brian Godman
    Division of Clinical Pharmacology, Department of Laboratory Medicine, Karolinska Institutet, Karolinska University Hospital Huddinge, SE 141 86, Stockholm, Sweden
    Appl Health Econ Health Policy 11:383-93. 2013
    ..However, depression is more complex to treat, with physicians reluctant to change prescriptions if patients are responding to a particular antidepressant...
  18. doi request reprint Risk scoring and thromboprophylactic treatment of patients with atrial fibrillation with and without access to primary healthcare data: experience from the Stockholm health care system
    Tomas Forslund
    Karolinska Institutet, Department of Medicine Solna, Clinical Pharmacology Unit, Karolinska University Hospital, SE 171 76 Stockholm, Sweden Electronic address
    Int J Cardiol 170:208-14. 2013
    ....
  19. doi request reprint Factors associated with pregabalin dispensing at higher than the approved maximum dose
    Robert Boden
    Centre for Pharmacoepidemiology at the Department of Medicine, Karolinska Institutet, Stockholm, Sweden
    Eur J Clin Pharmacol 70:197-204. 2014
    ..Therefore, the aim of our study was to characterize patients dispensed pregabalin at higher than the maximum allowed dose in a cohort study based on data extracted from Swedish national registers...
  20. doi request reprint Persistence to antihypertensive drug treatment in Swedish primary healthcare
    Miriam Qvarnström
    Department of Medicine, Solna, Karolinska Institutet, Centre for Pharmacoepidemiology, T2, Karolinska University Hospital, SE 171 76, Stockholm, Sweden
    Eur J Clin Pharmacol 69:1955-64. 2013
    ..To determine factors associated with low persistence in patients initiated on drug treatment for hypertension...
  21. doi request reprint Sex differences in spontaneous reports on adverse bleeding events of antithrombotic treatment
    Diana M Rydberg
    Clinical Pharmacology, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden
    Eur J Clin Pharmacol 70:117-26. 2014
    ..To explore if sex differences are found in spontaneously reported adverse events for clopidogrel, low-dose aspirin and warfarin treatment in routine care...
  22. doi request reprint The epidemiology of heart failure, based on data for 2.1 million inhabitants in Sweden
    Ramin Zarrinkoub
    Karolinska Institutet, Department of Neurobiology, Care Sciences and Society, Centre for Family Medicine, Huddinge, Sweden
    Eur J Heart Fail 15:995-1002. 2013
    ..Prevailing information is in part old, incomplete, and to some extent contradictory. We determined the current prevalence, incidence, mortality, and 5-year survival rate of CHF, and possible temporal changes in Sweden...
  23. doi request reprint A method to include the environmental hazard in drug prescribing
    Staffan Castensson
    Research and Development, National Corporation of Swedish Pharmacies, Apoteket AB, 118 81, Stockholm, Sweden
    Pharm World Sci 31:24-31. 2009
    ..Drug prescribing was calculated on all pharmacy sales of medicines in ambulatory care in Stockholm, Sweden (1.9 million inhabitants) during 2006...
  24. doi request reprint Diffusion of interferon beta in Iran and its utilization in Tehran
    Mohammad Palesh
    Division of International Health IHCAR, Department of Public Health Sciences, Karolinska Institutet, Sweden
    Pharmacoepidemiol Drug Saf 17:934-41. 2008
    ....
  25. pmc Nationwide drug-dispensing data reveal important differences in adherence to drug label recommendations on CYP2D6-dependent drug interactions
    Buster Mannheimer
    Karolinska Institutet, Department of Internal Medicine at Södersjukhuset, Stockholm, Sweden
    Br J Clin Pharmacol 69:411-7. 2010
    ..Dispensing data on drug combinations involving selective serotonin reuptake inhibitor (SSRI) antidepressants could help to identify areas for intensified medical education...